MAM
Spinn’s clarion call to agencies to spin an ad
MUMBAI: A perfect excuse for ad agencies to blow their own trumpet! Spinn, a chic bar located at Residency Road, has announced a contest, inviting advertising professional.
A call to the wacky, freaky professional advertising brains to put on their thinking caps, as Spinn calls it, the contest invites entries from ad agencies in and around Bangalore for a unique ad contest on the topic, “the humorous side of ad world”.
As humorous and wacky it gets, the more the jury laughs your entry out, the better your chances of winning, proclaims a company release.
Spinn would put together a team of leading industry stalwarts in Bangalore to judge the entries. The deadline for submission of entries is 25 May 2004. But the company will not entertain more than three entries from each ad agency. The entries can be mailed to spinnbng@yahoo.com.
According to Spinn’s managing partner Rajanna, “Being in the business of entertainment we understand the value of advertising and have personally noticed some of them to be very unique, offbeat and colorful individuals. This contest is our way of capturing that of course in a humorous manner with no offence meant. The entries would be displayed in Spinn at a later date as a special Talent Hub feature.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
